Global Antibiotic R&D Partnership (GARDP)
banner
gardp.bsky.social
Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).

https://gardp.org/this-is-big/
📍GARDP at #WCSJ2025

Join our workshop on making AMR stories more impactful, featuring Carol Ruffell from GARDP Africa.

🗓️ 02:00 PM on 02 December
📍Pretoria, South Africa

Register: https://wcsj2025.pulse.ly/ymgayawsuk

#ScienceJournalism #AMR
November 25, 2025 at 6:59 AM
🌍 As World AMR Awareness Week 2025 concludes, GARDP’s work of developing new antibiotics, repurposing existing ones and ensuring access for all continues.

Act Now: Protect Our Present, Secure Our Future.

#WAAW2025 #AMR #ThisIsBig #Antibiotics #GARDP
November 24, 2025 at 2:59 PM
As #USAAW25 draws to a close, we at GARDP reaffirm that tackling #AntimicrobialResistance requires all of us joining forces. The health of people, animals and our shared environment is interconnected 🧬🌍

Let’s keep the momentum going beyond the week. #WAAW2025 #CDC
November 24, 2025 at 12:47 PM
💥 We’re at a critical tipping point. AMR deaths could rise 70% by 2050.

On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.

🔗 https://tinyurl.pulse.ly/pb09zirmta

#Thisisbig
November 24, 2025 at 9:45 AM
💥 Fewer than 3,000 scientists worldwide are working on antibiotic discovery, and progress is slowing.

We need bold action to develop new antibiotics that are both innovative and accessible to everyone, everywhere.

That’s what drives GARDP’s DER programme.

This is BIG.

#WAAW2025 #AMR #ThisIsBig
November 23, 2025 at 12:59 PM
🧬 The antibiotic pipeline is drying up, with only 90 antibiotics in development, and a small fraction addressing the most urgent threats.

In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.

#WAAW2025 #AMR #Antibiotics
November 23, 2025 at 7:02 AM
💡 #REVIVE is one of the most comprehensive platforms in antimicrobial R&D, bringing together resources like Antimicrobial Viewpoints, webinars, conferences and AntibioticDB to support researchers worldwide.

For early-career scientists, bridging this #AMR knowledge gap is BIG. 💊

#WAAW2025
November 22, 2025 at 12:59 PM
💡 AMR research faces a critical knowledge gap, fewer scientists entering the field and key lessons from antimicrobial R&D at risk of being lost.

Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.

#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 22, 2025 at 7:02 AM
In many low- and middle-income countries, fewer than 1 in 15 people with multidrug-resistant infections receive the treatment they need.

🤝 GARDP is working with partners to change that.

💊 THIS IS BIG.

#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 21, 2025 at 1:00 PM
Happening today as part of #WAAW2025! 🎤

Join the #AMR Poetry Slam with Swissnex India where science and art come together to spark new conversations on AMR.

🔗Register and join the poetry slam here:
https://pulse.pulse.ly/zzxa7qnmsw

Let’s use creativity to inspire action against #AMR.
November 21, 2025 at 9:42 AM
🌍More than 50 million deaths could be prevented by 2050 if effective antibiotics were made accessible. Yet in many countries, they remain unavailable or unaffordable.

In this video, Abhijit Roy explains how we are acting now to close the access gap.

#WAAW2025 #AMR #Antibiotics
November 21, 2025 at 7:01 AM
GARDP joined the high-level AMR conference today hosted by the Danish AMR Alliance and partners. Peter Beyer joined a panel on solutions to AMR, highlighting our work on innovative antibiotic treatments and the responsible introduction of antibiotics to high-burden settings.

#WAAW2025 #Thisisbig
November 20, 2025 at 4:59 PM
💊 Newborns are often the last in line for antibiotics and it takes decades to adapt adult treatments for children.

We need to improve the global #AMR response for children and newborns! 👶

GARDP is working to develop new treatments for children, especially newborns with sepsis.

#WAAW2025
November 20, 2025 at 12:59 PM
🎙️We partnered with DeFrontera on #WAAW2025 for a media science café with African journalists and beyond.

Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
November 20, 2025 at 11:00 AM
Echoing GAP-f’s message on #WorldChildrensDay 👶

This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
November 20, 2025 at 10:25 AM
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.

GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.

Watch Carol Ruffell share more this World Children’s Day.

#WAAW2025
November 20, 2025 at 7:03 AM
As part of #WAAW2025, GARDP’s Pierre Daram participated as a speaker in the WHO webinar - From Resistance to Resilience: Drug-Resistant Gonorrhoea in 2025

The session marked the launch of 2024 EGASP Data Report that underscores the need to preserve surveillance efforts against drug-resistant STIs.
November 19, 2025 at 1:51 PM
Gonorrhoea accounts for over 82 million new cases each year and has had no new treatment in more than 40 years.

GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.

THIS IS BIG.

#WAAW2025 #AMR
November 19, 2025 at 1:00 PM
🦠 Every day more than 1 million curable STIs are acquired. Drug-resistant gonorrhoea is spreading and treatment options are running out.

GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.

#WAAW2025 #AMR #Antibiotics #STIs
November 19, 2025 at 7:01 AM
📊 2025 Milestone from our SBIs programme

GARDP has signed an agreement with Bugworks Research to co-develop an oral version of BWC0977, a promising broad-spectrum antibiotic.

#WAAW2025
November 18, 2025 at 3:59 PM
As part of #WAAW2025, GARDP joined the SPEARHEAD event on sustaining the fight against AMR.
Peter Beyer spoke on our R&D and access model, and Damien Somé moderated a panel on AMR’s impact and future preparedness.

📸 Jasmin Frei Fotografin Zürich
November 18, 2025 at 2:00 PM
🏥 Serious bacterial infections remain a leading cause of death in healthcare settings.

THIS IS BIG and GARDP is advancing new treatments for both children and adults.

📢 Share and join the #ThisIsBig campaign.
🔗https://gardp.pulse.ly/xhmaju3qfi

#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 18, 2025 at 1:00 PM
Serious bacterial infections cause 7.7M deaths every year.
Drug resistance is outpacing innovation, leaving few safe treatments.

François Franceschi explains how GARDP is acting now to change this.

#WAAW2025 #AMR #Antibiotics
November 18, 2025 at 9:01 AM
🚀 Today kicks off World AMR Awareness Week 2025!

Drug-resistant infections are one of the biggest threats to global health, but action is growing worldwide.

All week we’ll share how GARDP is working with partners to develop & deliver the antibiotics we urgently need.

@who.int

#WAAW2025
November 18, 2025 at 5:59 AM
🚨 Final Day to Submit!

Today’s your last chance to send in your abstract for #ACC2026.

🕔Deadline: 1700 GMT

Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.

👉 Submit before time runs out: acc-conference.com#posters
November 14, 2025 at 10:43 AM